May Failure to Thrive in Infants Be a Clinical Marker for the Early Diagnosis of Cow's Milk Allergy?


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
13 Feb 2020
Historique:
received: 26 12 2019
revised: 07 02 2020
accepted: 09 02 2020
entrez: 20 2 2020
pubmed: 20 2 2020
medline: 20 11 2020
Statut: epublish

Résumé

Objectives-Failure to thrive (FTT) in infants is characterized by growth failure. Although, cow's milk allergy (CMA) may have an impact on growth and leads to FTT, data are still limited. We focused on FTT as a possible clinical marker for an early diagnosis of CMA. The aim of the present study was to evaluate the implications of cow's milk hypersensitivity in infants with FTT and the growth catch-up after a cow's milk-free diet (CMFD). Methods-A cross-sectional study of all consecutive infants evaluated at the Pediatric Nutrition and Allergy Unit of the University Hospital of Bari (Italy) from January 2016 to April 2018 with a medical-driven diagnosis of FTT. Eligible infants were investigated for possible IgE mediated or non-IgE mediated CMA. Results-43 infants were included, mean age 5.7 months. 33/43 (77%) FTT presented a CMA related disease: 3/43 (7%) were diagnosed as presenting an IgE mediated CMA, 30 (93%) had a non IgE-mediated CMA, confirmed by the elimination diet for diagnostic purposes, that led to a significant improvement of symptoms and recrudescence after milk reintroduction. A total of 29 out of 30 patients (one patient was lost at follow-up) moved up to their original growth percentile after dietary changes. Growth z-scores were computed based on WHO anthropometric data. In 10 out of 43 patients (23%) were diagnosed with gastro-esophageal reflux disease (GERD). Conclusions-when evaluating an infant with FTT, physicians should include in their evaluation an extensive search for IgE mediated and non IgE mediated CMA. When in vivo and in vitro analysis are not conclusive, a 4- to 8-weeks trial of CMFD and a consecutive re-introduction of milk proteins may be helpful in less common diagnoses.

Identifiants

pubmed: 32069783
pii: nu12020466
doi: 10.3390/nu12020466
pmc: PMC7071281
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Clin Pediatr (Phila). 2006 Jan-Feb;45(1):1-6
pubmed: 16429209
Nat Rev Gastroenterol Hepatol. 2017 Apr;14(4):241-257
pubmed: 27999436
Arch Dis Child. 2007 Feb;92(2):115-9
pubmed: 16905563
Allergol Immunopathol (Madr). 2008 Nov-Dec;36(6):313-4
pubmed: 19150028
Acta Paediatr. 2015 Apr;104(4):334-9
pubmed: 25557474
Arch Dis Child. 2007 Feb;92(2):109-14
pubmed: 16531456
Clin Transl Allergy. 2017 Aug 23;7:26
pubmed: 28852472
Br J Nutr. 2015 Apr 14;113(7):1102-12
pubmed: 25781481
Arch Dis Child. 2000 May;82(5):364-5
pubmed: 10799424
Clin Pediatr (Phila). 2008 Oct;47(8):762-5
pubmed: 18467671
Allergy. 2014 Aug;69(8):1008-25
pubmed: 24909706
Acta Paediatr Suppl. 2005 Oct;94(449):115-9
pubmed: 16214777
Int J Epidemiol. 2004 Aug;33(4):839-47
pubmed: 15155703
Clin Exp Allergy. 2014;44(5):642-72
pubmed: 24588904
JPEN J Parenter Enteral Nutr. 2013 Jul;37(4):460-81
pubmed: 23528324
Allergy. 2014 Aug;69(8):992-1007
pubmed: 24816523
Acta Paediatr. 2014 Jun;103(6):e243-50
pubmed: 24575806
J Allergy Clin Immunol. 2014 Nov;134(5):1016-25.e43
pubmed: 25174862
Clin Pediatr (Phila). 2012 Mar;51(3):219-25
pubmed: 21997145
Nutrients. 2019 Oct 08;11(10):
pubmed: 31597323
Pediatr Allergy Immunol. 2010 Jul;21 Suppl 21:1-125
pubmed: 20618740
Pediatrics. 2000 Aug;106(2 Pt 1):346-9
pubmed: 10920165
Allergy. 2004 Jul;59(7):690-7
pubmed: 15180754
J Pediatr Gastroenterol Nutr. 2012 Aug;55(2):221-9
pubmed: 22569527
J Allergy Clin Immunol. 2017 Apr;139(4):1111-1126.e4
pubmed: 28167094
J Allergy Clin Immunol. 2015 May;135(5):1114-24
pubmed: 25956013
Arch Dis Child. 2007 Feb;92(2):95-6
pubmed: 17264277

Auteurs

Lucia Diaferio (L)

Department of Pediatrics, Giovanni XXIII Hospital, University of Bari, 70126 Bari, Italy.
Département de Pneumologie et Addictologie, Allergy Unit, Hôpital Arnaud de Villeneuve, CHU de Montpellier, Univ Montpellier, 34000 Montpellier, France.

Davide Caimmi (D)

Département de Pneumologie et Addictologie, Allergy Unit, Hôpital Arnaud de Villeneuve, CHU de Montpellier, Univ Montpellier, 34000 Montpellier, France.
Epidemiology of Allergic and Respiratory Diseases Department (EPAR), IPLESP, UMR 1136 INSERM-Sorbonne Université, 75571 Paris, France.

Maria Carmen Verga (MC)

Primary Care Pediatrics, ASL Salerno, 84019 Vietri sul Mare (SA), Italy.

Valentina Palladino (V)

Department of Pediatrics, Giovanni XXIII Hospital, University of Bari, 70126 Bari, Italy.

Lorenzo Trovè (L)

Department of Pediatrics, Giovanni XXIII Hospital, University of Bari, 70126 Bari, Italy.

Paola Giordano (P)

Department of Pediatrics, Giovanni XXIII Hospital, University of Bari, 70126 Bari, Italy.

Elvira Verduci (E)

Department of Pediatrics, San Paolo Hospital, Department of Health Science, University of Milan, 20142 Milan, Italy.

Vito Leonardo Miniello (VL)

Department of Pediatrics, Giovanni XXIII Hospital, University of Bari, 70126 Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH